Skip to content
Clinical Trials – home

SULFAMETHOXAZOLE: A Comprehensive Guide for Patients

37 / 41
trials open to patients / all trials
17+
Countries

In short

Sulfamethoxazole is an antibiotic medication that is commonly used in combination with trimethoprim (often abbreviated as TMP-SMX) for treating various bacterial infections and as a preventive measure against certain opportunistic infections. This article explores the use and effectiveness of sulfamethoxazole in clinical trials for different medical conditions.

At a glance

Primary Uses
Treatment and prevention of Pneumocystis jirovecii pneumonia (PJP), skin abscesses, prophylaxis in immunocompromised patients
Common Dosage Forms
Oral tablets, suspension; usually combined with trimethoprim (TMP-SMX)
Target Populations
HIV patients, those with autoimmune diseases, patients on immunosuppressive treatments
Effectiveness
Shown to be effective in preventing PJP and treating various bacterial infections
Side Effects
Nausea, skin rashes, liver enzyme abnormalities; rare severe reactions possible
Research Focus
Optimal dosing regimens, duration of treatment, use in specific patient populations

What is Sulfamethoxazole?

Sulfamethoxazole is an antibiotic medication that is often used in combination with another antibiotic called trimethoprim. This combination is known as co-trimoxazole, and it's commonly referred to by brand names such as Bactrim, Septra, or Sulfatrim. Sulfamethoxazole belongs to a class of drugs called sulfonamides, which are synthetic antibiotics used to treat various bacterial infections.

Uses of Sulfamethoxazole

Sulfamethoxazole, typically in combination with trimethoprim, is used to treat a wide variety of bacterial infections. Some of the common conditions it's used for include:

  • Urinary tract infections (UTIs): It's effective against bacteria that cause UTIs.
  • Pneumocystis jirovecii pneumonia (PJP): This is a type of pneumonia that often affects people with weakened immune systems, such as those with HIV/AIDS.
  • Skin infections: Including abscesses caused by bacteria like Staphylococcus aureus.
  • Ear infections, bronchitis, and traveler's diarrhea.
  • Prevention of infections: In some cases, it's used to prevent infections in people with weakened immune systems or certain chronic conditions.

How Sulfamethoxazole Works

Sulfamethoxazole works by interfering with the ability of bacteria to produce folic acid, which is essential for their growth and reproduction. When combined with trimethoprim, the two drugs work together to block different steps in the bacterial folic acid synthesis pathway, making the combination more effective than either drug alone.

Dosage and Administration

The dosage of sulfamethoxazole can vary depending on the specific condition being treated, the patient's age, weight, and other factors. It's typically taken orally in tablet form, but can also be given intravenously in some cases. For example:

  • For treating skin abscesses in children, a common dose is 10 mg of trimethoprim per kg of body weight per day, divided into two doses, for 3 to 10 days.
  • For preventing Pneumocystis jirovecii pneumonia in adults with certain conditions, a dose of 80 mg trimethoprim/400 mg sulfamethoxazole taken daily may be used.

It's crucial to take the medication exactly as prescribed by your healthcare provider and complete the full course of treatment, even if you start feeling better before it's finished.

Effectiveness of Sulfamethoxazole

Sulfamethoxazole, especially when combined with trimethoprim, has been shown to be effective in treating and preventing various infections. For instance:

  • It has been found effective in reducing the rate of urinary tract infections in pregnant women with recurrent infections.
  • In treating skin abscesses, a study found that 3 days of treatment was as effective as 10 days in most cases.
  • It's been shown to be effective in preventing Pneumocystis jirovecii pneumonia in patients with weakened immune systems.

Side Effects and Safety

Like all medications, sulfamethoxazole can cause side effects. Common side effects may include:

  • Nausea, vomiting, or loss of appetite
  • Skin rashes or itching
  • Headache
  • Dizziness

More serious side effects, though less common, can include severe skin reactions, liver problems, or blood disorders. It's important to seek medical attention if you experience any unusual or severe side effects.

Special Considerations

There are several important considerations when using sulfamethoxazole:

  • Pregnancy: The safety of sulfamethoxazole during pregnancy is not fully established. Always consult with your healthcare provider if you're pregnant or planning to become pregnant.
  • Kidney function: The dosage may need to be adjusted in people with kidney problems.
  • Allergies: People with known allergies to sulfa drugs should not take sulfamethoxazole.
  • Drug interactions: Sulfamethoxazole can interact with other medications, so it's important to inform your healthcare provider about all medications you're taking.

Remember, while this information provides a general overview, it's crucial to consult with your healthcare provider for personalized advice and information about using sulfamethoxazole.

Questions people often ask

Conditions where Sulfamethoxazole is being studied

Each condition opens its own overview and trial list

Trials with Sulfamethoxazole

Recruiting trials first

See all 41 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).